Pharmaceutical Regulatory Affairs in Russia, the Eurasian Union and the CIS 2018

Pharmaceutical Regulatory Affairs in Russia, the Eurasian Union and the CIS is organized by Management Forum (Mf) Ltd and will be held during Mar 01 - 02, 2018 at The Rembrandt Hotel, London, England, United Kingdom.

The target audience for this medical event is anyone working in pharmaceutical regulatory affairs in this region and anyone interested in an update of recent developments.

Conference Description :
The aim of this meeting is to provide an overview of recent regulatory developments in pharmaceutical regulatory affairs in Russia and the Eurasian Union. This interactive meeting will discuss the regulatory requirements within these regions, and discuss the implications of the new joint Eurasian Union regulation, which came into force in 2016. The focus will be on practical aspects to assist in developing your regulatory strategy for product approval in these countries and the presentations will also give practical hints on the regulatory process where possible.

Benefits of attending :
Attending this programme will :
• Give you the full background to the CIS pharmaceutical market
• Ensure that you understanding the full implications of the new regulations which will effect how you do business in the Eurasian Economic Union (EAEU)
• Fully update you on the national regulations in Russia, Belarus, Kazakhstan, Ukraine and other CIS countries

Fee Details :
Conference Fee : €2518.80
Multiple booking discount for 2nd or subsequent delegates Fee : €2140.98

Additional details will be posted as soon as they are available.